2022
Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance
JESTER, Dylan J., Martin VYHNALEK, Ross ANDEL, Hana MARKOVA, Tomas NIKOLAI et. al.Základní údaje
Originální název
Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance
Autoři
JESTER, Dylan J. (garant), Martin VYHNALEK (203 Česká republika), Ross ANDEL, Hana MARKOVA (203 Česká republika), Tomas NIKOLAI, Jan LACZO, Veronika MATUSKOVA (203 Česká republika), Katerina CECHOVA (203 Česká republika), Kateřina SHEARDOVÁ (203 Česká republika, domácí) a Jakub HORT (203 Česká republika)
Vydání
Journal of Alzheimers Disease, Amsterdam, IOS Press, 2022, 1387-2877
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.000
Kód RIV
RIV/00216224:14110/22:00128319
Organizační jednotka
Lékařská fakulta
UT WoS
000784452600020
Klíčová slova anglicky
Cognitive aging; immediate recall; subjective memory complaints; verbal memory
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2023 11:13, Mgr. Tereza Miškechová
Anotace
V originále
Background: Older adults with subjective cognitive decline (SCD) are at an increased risk of progression to mild cognitive impairment (MCI) or dementia. However, few have examined the specific cognitive tests that are associated with progression. Objective: This study examined performance on 18 neuropsychological tests among participants with SCD who later progressed to MCI or dementia. Methods: We included 131 participants from the Czech Brain Aging Study that had SCD at baseline. They completed a comprehensive neuropsychological battery including cognitive tests from the Uniform Data Set 2.0 enriched by the verbal memory test Rey Auditory Verbal Learning Test (RAVLT) and Rey-Osterrieth Complex Figure Test (ROCFT). Results: Fifty-five participants progressed: 53% to non-amnestic MCI (naMCI), 44% to amnestic MCI (aMCI), and 4% to dementia. Scoring one SD below the mean at baseline on the RAVLT 1 and RAVLT 1-5 was associated with 133% (RAVLT 1; HR: 2.33 [1.50, 3.62]) and 122% (RAVLT 1-5; HR: 2.22 [1.55, 3.16]) greater risk of progression to MCI or dementia over 3.84 years on average. Worse performance on the RAVLT 5, RAVLT 1-5, RAVLT 30, and ROCFT-Recall was associated with progression to aMCI whereas worse performance on the RAVLT 1, TMT B, and Boston Naming Test was associated with progression to naMCI. Conclusion: At baseline, lower verbal memory performance was most strongly associated with progression to aMCI whereas lower executive or language performance was most strongly associated with progression to naMCI.